The Neurometabolomics and Neuroinformatics Core will use analytics tools like mass spectrometry, spectrophotometry and nuclear magnetic resonance spectroscopy to determine how inherited metabolic diseases affect the nervous system and contribute to disorders like Alzheimer’s, Parkinson’s, multiple sclerosis and addiction.
The program will also assist scientists from other organizations. “After performing the pertinent experiments in their own labs, they can submit samples to our core for processing, data analysis, visualization, interpretation and mathematical modeling,” said Mount Sinai pediatric neurologist Isaac Marin-Valencia, MD, in a Feb. 2 news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
